Target
Mitogen-activated protein kinase 13
Ligand
BDBM50473622
Substrate
n/a
Meas. Tech.
ChEMBL_124318 (CHEMBL732626)
IC50
12±n/a nM
Citation
 McKenna, JMHalley, FSouness, JEMcLay, IMPickett, SDCollis, AJPage, KAhmed, I An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem 45:2173-84 (2002) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase 13
Synonyms:
MAP kinase 13 | MAP kinase p38 delta | MAPK 13 | MK13_MOUSE | Mapk13 | Mitogen-activated protein kinase 13 | Mitogen-activated protein kinase p38 delta | Serk4 | Stress-activated protein kinase 4
Type:
PROTEIN
Mol. Mass.:
42081.17
Organism:
Mus musculus
Description:
ChEMBL_105000
Residue:
366
Sequence:
MSLTRKRGFYKQDINKTAWELPKTYLAPAHVGSGAYGAVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMHHENVIGLLDVFTPASSLRSFHDFYLVMPFMQTDLQKIMGMEFSEDKVQYLVYQMLKGLKYIHSAGIVHRDLKPGNLAVNEDCELKILDFGLARHTDTEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGAEFVQKLKDKAAKSYIQSLPQSPKKDFTQLFPRASPQAADLLDKMLELDVDKRLTAAQALAHPFFEPFRDPEEETEAQQPFDDALEHEKLSVDEWKQHIYKEISNFSPIARKDSRRRSGMKLQ
  
Inhibitor
Name:
BDBM50473622
Synonyms:
CHEMBL70705 | RPR-239497
Type:
Small organic molecule
Emp. Form.:
C26H31FN6O3
Mol. Mass.:
494.5611
SMILES:
CC(C)NC(=O)[C@@]1(C)CO[C@@H](OC1)c1nc(c([nH]1)-c1ccnc(NCC2CC2)n1)-c1ccc(F)cc1 |wU:10.13,6.6,wD:6.5,(22.4,-13.11,;23.18,-11.78,;24.72,-11.79,;22.42,-10.43,;20.88,-10.43,;20.1,-11.76,;20.11,-9.1,;20.88,-7.77,;19.35,-7.77,;17.82,-7.77,;17.04,-9.1,;17.82,-10.43,;19.33,-10.43,;15.5,-9.1,;14.59,-10.34,;13.12,-9.86,;13.13,-8.3,;14.61,-7.84,;11.8,-7.53,;11.8,-5.99,;10.45,-5.22,;9.12,-5.99,;9.12,-7.53,;7.79,-8.3,;6.46,-7.53,;5.12,-8.3,;3.58,-8.3,;4.35,-9.64,;10.45,-8.3,;11.88,-10.76,;12.04,-12.28,;10.8,-13.19,;9.38,-12.56,;8.04,-13.32,;9.22,-11.01,;10.48,-10.12,)|
Structure:
Search PDB for entries with ligand similarity: